IL18 and Stroke: Compared to probucol alone, Tongxinluo combined with probucol significantly reduces serum levels of ox-LDL, MMP-7, and IL-18 in stroke patients, suggesting a potential role in delaying or reversing the progression of carotid atherosclerotic plaques. No significant adverse reactions were observed during the treatment period.